Get the latest Science News and Discoveries
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK
TRI-611 induces the degradation of ALK fusion proteins via a previously undescribed CRBN recruitment motif, and its preclinical anti-tumour activity highlights TRI-611 as a potential new way of treating ALK-positive non-small-cell lung cancer.
None
Or read this on Nature
